Clinical Trials
23 trialsNCT02635360 2025-07-03
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
University of Virginia
Phase 2 Completed
NCT03107182 2025-05-06
OPTIMA-II
University of Chicago
Phase 2 Completed
NCT03527264 2025-04-04
BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer
Brown University
Phase 2 Terminated
NCT05546411 2024-12-17
A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT04866017 2024-10-31
A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer
BeiGene
Phase 3 Terminated
NCT04952597 2024-10-26
Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer
BeiGene
Phase 2 Completed
NCT03490292 2024-07-26
Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer
University of Wisconsin, Madison
Phase 1/2 Completed
NCT01581840 2024-07-01
Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus
Federation Francophone de Cancerologie Digestive
Phase 1/2 Completed
NCT01515787 2024-02-02
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Alliance for Clinical Trials in Oncology
Phase 2/3 Unknown
NCT01470417 2023-08-22
GAIN-1
University of Florida
Phase 2 Completed
NCT02207439 2023-07-25
Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT02952586 2021-09-22
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Pfizer
Phase 3 Terminated
NCT01365156 2021-02-03
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
M.D. Anderson Cancer Center
Phase 3 Completed
NCT03745222 2020-07-15
RATIONALE001
Celgene
Phase 3 Terminated
NCT02431572 2020-04-28
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
Massachusetts General Hospital
Phase NA Completed
NCT01362127 2020-02-26
NeoRes
Karolinska University Hospital
Phase 2 Completed
NCT02716896 2019-11-25
Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase NA Terminated
NCT02301143 2019-03-20
LAPACT
Celgene
Phase 2 Completed
NCT03223662 2018-10-30
Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT01507103 2017-01-13
SPRINT
Merck KGaA, Darmstadt, Germany
Phase 2 Completed
NCT00424255 2014-07-18
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
GlaxoSmithKline
Phase 3 Completed
NCT00140556 2013-01-18
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
Duke University
Phase EARLY_PHASE1 Completed
NCT00831493 2012-02-28
Vorinostat Plus Radiation Therapy in Pancreatic Cancer
M.D. Anderson Cancer Center
Phase 1/2 Terminated